Porcine Reproductive & Respiratory Syndrome roadmap:
Vaccines
Roadmap for development of a candidate vaccine for PRRSV
Download PRRSV Vaccine Roadmap14
Identity of immunomodulators
Dependencies
- 17 Host-pathogen interactions
- 17A Entry
- 17B Replication
- 17C Persistence/ clearance
Next steps
To establish the identity of the immunomodulatory factors/stealth mechanisms in PRRSV
Research Question
- PRRSV attempts to modulate the host’s immune responses so that it can survive and replicate
- The early Ab response isn’t protective and VN-Abs don’t appear until 6 weeks into infection
- Identifying and removal of the factors contributing to the virus stealth mechanisms could contribute to the generation of improved attenuated vaccine candidates
Solution Routes
- Generation of a range of knock-out viruses where the genes for various immunomodulatory factors or other stealth mechanisms have been removed and their use in experimental infections
- Modulation of innate immune responses
Dependencies
- Improved understanding of virus-macrophage interaction – viral and macrophage gene expression in different in vivo environments (macrophages from naïve and immune hosts)
Projects
What activities are planned or underway?
Immune responses induced by inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccine in neonate pigs using different adjuvants
Planned Completion date 01/02/2021
Source Countries:
Netherlands
Modified live vaccine strains of porcine reproductive and respiratory syndrome virus cause immune system dysregulation similar to wild strains.
Planned Completion date 12/01/2024
Source Countries:
Netherlands